Source: Virtual Congress 2020 – Diagnosis and management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Ji (Madrid, Spain), J. Hernández Vázquez (Madrid, Spain), C. Castro Riera (Madrid, Spain), J. Bellón Cano (Madrid, Spain), V. Gallo González (Madrid, Spain), B. Recio Moreno (Madrid, Spain), A. Cerezo Lajas (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel Díez (Madrid, Spain). Influence of pneumonia on the survival of patients with COPD. 105

Member's Comments

No comment yet.

Related content which might interest you: Effects of heliox-therapy on saturation and of survival patients with execerbation of COPD Source: Annual Congress 2007 - Exercise: measurements, techniques and paradigms Year: 2007 Impact of pneumonia on mortality and length of stay in patients hospitalized with acute COPD exacerbations Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Characteristics and outcomes in patients with COPD receiving machanical ventilation: Indication, survival and occurance of ventilator-associated pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 14s Year: 2003 Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Updates in pneumonia in patients with COPD Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II Year: 2014 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Prognosis and evolution of COPD patients hospitalized and treated with non invasive ventilation Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia Source: Eur Respir J 2011; 37: 36-41 Year: 2011 One-year survival in patients hospitalized due to an acute exacerbation of COPD. Related factors Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Predictors of survival in severe COPD patients initiated on chronic NIV Source: International Congress 2016 – New horizons for noninvasive ventilation in acute and chronic settings Year: 2016 Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer Source: Eur Respir Rev 2008; 17: 83-85 Year: 2008 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis Source: International Congress 2017 – COPD and weaning Year: 2017 Prognostic evaluation of COPD patients with pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005 Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006